How much revenue does Venmax Drugs AND Pharmaceutica make?

Venmax Drugs AND Pharmaceutica reported 80.25 million INR in revenue for fiscal year 2026, up 894.0% from 8.07 million INR in fiscal year 2025. In Q1 2027 revenue was 24.79 million INR.

What companies are similar to Venmax Drugs AND Pharmaceutica?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Chandra Bhagat Pharma Ltd (CBPL.BO), Medico Intercontinental Limited (MIL.BO), Welcure Drugs and Pharmaceuticals Limited (WELCURE.BO), Chemo Pharma Laboratories Limited (CHEMOPH.BO).

Venmax Drugs AND Pharmaceutica (VENMAX.BO) Stock

About Venmax Drugs AND Pharmaceutica

Venmax Drugs and Pharmaceuticals Limited engages in the business of pharmaceutical products, drug intermediaries, and API's in India. The company was formerly known as Yenkey Drugs & Pharmaceuticals Ltd and changed its name to Venmax Drugs and Pharmaceuticals Limited in April 2009. Venmax Drugs and Pharmaceuticals Limited was incorporated in 1988 and is based in Hyderabad, India.

At a glance

Venmax Drugs AND Pharmaceutica reported revenue of 80.25 million INR for fiscal year 2026, up 894.0% from fiscal year 2025, and net income of 2.48 million INR. In Q1 2027 (the quarter ended June 30, 2026) revenue was 24.79 million INR, up 104.9% from a year before.

Figures from company filings; latest fiscal year ended March 31, 2026.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.